PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24719110-3	2014	In addition, intrathecal GLP-1R agonists GLP-1(7-36) and exenatide potently alleviated formalin-, peripheral nerve injury-, bone cancer-, and diabetes-induced hypersensitivity states by 60-90%, without affecting acute nociceptive responses.	Exenatide	57-66	glucagon-like peptide 1 receptor	Rattus norvegicus	25-31	
24719110-4	2014	The antihypersensitive effects of exenatide and GLP-1 were completely prevented by GLP-1R antagonism and GLP-1R gene knockdown.	Exenatide	34-43	glucagon-like peptide 1 receptor	Rattus norvegicus	83-89	
24719110-4	2014	The antihypersensitive effects of exenatide and GLP-1 were completely prevented by GLP-1R antagonism and GLP-1R gene knockdown.	Exenatide	34-43	glucagon-like peptide 1 receptor	Rattus norvegicus	105-111